| California Eye And Ear Specialists Medical Group | |
|
100 E California Blvd, Pasadena, CA 91105-3205 | |
| (626) 568-8838 | |
| (626) 796-7657 |
| Full Name | California Eye And Ear Specialists Medical Group |
|---|---|
| Type | Facility |
| Speciality | Ophthalmology |
| Location | 100 E California Blvd, Pasadena, California |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114205432 | NPI | - | NPPES |
| 1114205432 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (California) | Secondary |
| 207W00000X | Ophthalmology | (California) | Primary |
| 207WX0107X | Ophthalmology - Retina Specialist | (California) | Secondary |
| Provider Name | Michael A Samuel |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1730175670 PECOS PAC ID: 7315910858 Enrollment ID: I20040813000731 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Don A Adkins |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1740264183 PECOS PAC ID: 5294799193 Enrollment ID: I20041118001060 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Phuc Quach |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1770617805 PECOS PAC ID: 5294755195 Enrollment ID: I20051206000643 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Richard V Packard |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1942358320 PECOS PAC ID: 2961424452 Enrollment ID: I20051227000641 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Tom S Chang |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1609848969 PECOS PAC ID: 7113931056 Enrollment ID: I20060201000549 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Jeffrey P Wasserstrom |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1710922687 PECOS PAC ID: 7012911290 Enrollment ID: I20060830000314 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Paul M Bonds |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1346320645 PECOS PAC ID: 1355440934 Enrollment ID: I20070621000756 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Bruce T Haight |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1427029628 PECOS PAC ID: 9032289897 Enrollment ID: I20080605000207 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Anthony Culotta |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1497790018 PECOS PAC ID: 5991878332 Enrollment ID: I20090326000464 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Michael R Rose |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1861593006 PECOS PAC ID: 9335176668 Enrollment ID: I20100209000695 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Kristie Lin |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1184801557 PECOS PAC ID: 2365506425 Enrollment ID: I20110726000291 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Kevin K Suk |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1326257569 PECOS PAC ID: 4688711187 Enrollment ID: I20110822000424 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Reid Wainess |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1396935979 PECOS PAC ID: 9638340524 Enrollment ID: I20110926000815 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Evelyn M Perez |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1124101084 PECOS PAC ID: 3274792007 Enrollment ID: I20120313000941 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Martha Patricia Buckley |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1376844993 PECOS PAC ID: 5395900781 Enrollment ID: I20120710000605 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Lily F Lee |
|---|---|
| Provider Type | Practitioner - Plastic And Reconstructive Surgery |
| Provider Identifiers | NPI Number: 1730311226 PECOS PAC ID: 0143478495 Enrollment ID: I20120912000324 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Murtaza Merali |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1972944189 PECOS PAC ID: 9133353089 Enrollment ID: I20131008000401 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Jessica M Boeckmann |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1629210679 PECOS PAC ID: 9234364464 Enrollment ID: I20131024001166 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Kweku Grant-acquah |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1831327626 PECOS PAC ID: 2264667294 Enrollment ID: I20131029002250 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Marineh Baghoumian |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1972929438 PECOS PAC ID: 5294950796 Enrollment ID: I20140625001021 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Juliane Lee |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1780890749 PECOS PAC ID: 0143445551 Enrollment ID: I20140626002608 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Brian H Chen |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1952631632 PECOS PAC ID: 9335365501 Enrollment ID: I20140723002578 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Ling Y Bei |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1164740460 PECOS PAC ID: 4789813361 Enrollment ID: I20140828000101 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Dana Le |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1285030015 PECOS PAC ID: 1153645379 Enrollment ID: I20150117000082 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Grace T Chi |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1366607558 PECOS PAC ID: 4880759471 Enrollment ID: I20150130001992 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Wesley S Chew |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1952714446 PECOS PAC ID: 4385969708 Enrollment ID: I20150205002646 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Heidrun Elisabeth Gollogly |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1477879823 PECOS PAC ID: 0648449157 Enrollment ID: I20150508000732 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Avneet Kaur Sodhi-gaur |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1982929105 PECOS PAC ID: 9739306614 Enrollment ID: I20150819006484 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Anuj Chawla |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1083841027 PECOS PAC ID: 0244458024 Enrollment ID: I20150824002631 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Henry V Tran |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1467846709 PECOS PAC ID: 3476860388 Enrollment ID: I20150909002502 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Hardeep Kataria |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1043564362 PECOS PAC ID: 8921223454 Enrollment ID: I20151110002655 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Morgan E Renner |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1649565920 PECOS PAC ID: 7517270044 Enrollment ID: I20160719000677 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Elizabeth Du |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1730393398 PECOS PAC ID: 7012104995 Enrollment ID: I20160919002522 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Ashley Ann Alden |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1851742738 PECOS PAC ID: 4183902000 Enrollment ID: I20161027002539 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Melody J Kim |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1487082749 PECOS PAC ID: 2567743537 Enrollment ID: I20170105001313 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Joel M Solano |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1952380834 PECOS PAC ID: 0042235798 Enrollment ID: I20170131001515 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Sanjeev Grewal |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1972573103 PECOS PAC ID: 0840483046 Enrollment ID: I20170223001907 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Sharon M Dyer |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1063866887 PECOS PAC ID: 6204124233 Enrollment ID: I20170403002195 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Tarek Alasil |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1003072786 PECOS PAC ID: 6406048727 Enrollment ID: I20170523002897 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Jeffrey L Stevens |
|---|---|
| Provider Type | Practitioner - Ophthalmology |
| Provider Identifiers | NPI Number: 1114254711 PECOS PAC ID: 1153446950 Enrollment ID: I20170524001705 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Provider Name | Kathy Mao |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1053830158 PECOS PAC ID: 9638430101 Enrollment ID: I20180223001709 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| California Eye And Ear Specialists Medical Group 100 E. California Blvd, Pasadena, CA 91105-3205 Ph: (888) 884-3805 | California Eye And Ear Specialists Medical Group 100 E California Blvd, Pasadena, CA 91105-3205 Ph: (626) 568-8838 |
News Archive
Neurological research and clinical care received a significant boost today as Imperial College London and McGill University of Montreal entered an agreement enabling them to work more closely together in this field.
Rehabilitation specialists guiding injured workers back to full-time employment should factor unconventional work schedules into their assessments and planning, new research suggests.
Moving to expand its product offering, Medtronic, Inc., announced today that it has completed the acquisition of Invatec, a developer of innovative medical technologies for the interventional treatment of cardiovascular disease.
Senate lawmakers will begin debate today on a reconciliation bill "fixing" the health reform overhaul that has been approved by both the House and the Senate. Democrats hope to finish consideration of the legislation by Saturday.
Results from the START clinical study (Study of Thymoglobulin to Arrest Newly Diagnosed Type 1 Diabetes), led by Dr. Steve Gitelman (University of California, San Francisco) and sponsored by the Immune Tolerance Network, are published today in The Lancet Diabetes & Endocrinology.
› Verified 1 days ago